Conquista Lubrificare dizionario auy922 clinical trials cubo Sulla testa di Approvazione
The Anticancer Drug AUY922 Generates a Proteomics Fingerprint That Is Highly Conserved among Structurally Diverse Hsp90 Inhibitors | Journal of Proteome Research
The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage | PLOS ONE
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models | Breast Cancer Research | Full Text
Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer
Proteomics Fingerprints of Auy922 and 17-dmag Indicate Common Mechanisms of Action for Hsp90 Inhibitors
NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis | Cell Death Discovery
Luminespib - Wikipedia
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma - Augello - 2019 - International Journal of Cancer - Wiley Online Library
Exploring the inhibitory mechanism of resorcinylic isoxazole amine NVP- AUY922 towards the discovery of potential heat shock protein 90 (Hsp90) inhibitors - ScienceDirect
Targeting HSP90 by the Novel Inhibitor NVP-AUY922 Reduces Growth and Angiogenesis of Pancreatic Cancer | Anticancer Research
Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer | PGPM
Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer - ScienceDirect
HSP90 Inhibitor, NVP-AUY922, Improves Myelination in Vitro and Supports the Maintenance of Myelinated Axons in Neuropathic Mice | ACS Chemical Neuroscience
Luminespib - an overview | ScienceDirect Topics
Frontiers | Complex Crystal Structure Determination of Hsp90N-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922
Phase 1/1B trial of the heat shock protein 90 inhibitor NVP‐AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma - Seggewiss‐Bernhardt - 2015 - Cancer -
Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells | Anticancer Research
NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis | Cell Death Discovery
The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage | PLOS ONE
NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis | Cell Death Discovery
Luminespib - an overview | ScienceDirect Topics
Frontiers | Complex Crystal Structure Determination of Hsp90N-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922
NVP-AUY922 inhibits downstream signaling of IGF-1Rβ and exerts... | Download Scientific Diagram
Hsp90 phase II candidate | Vernalis Research
Full article: Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non–Small Cell Lung Cancer - Journal of Thoracic Oncology